Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis

By sjmartinez • February 28, 2023

Kuraji R, Shiba T, Dong TS, Numabe Y, Kapila YL. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis. World J Gastroenterol. 2023 Feb 14;29(6):967-996. doi: 10.3748/wjg.v29.i6.967. PMID: 36844143; PMCID: PMC9950865.

Tags: Digestive Diseases, Dysbiosis, Metabolic syndrome, Microbiota, Nonalcoholic fatty liver disease, Periodontal disease, probiotics, Publications

Increasing Goals of Care Discussions Among Veterans with Cirrhosis: A Veterans Health Administration Quality Improvement Initiative

Patel AA, O'Leary JG, Bajaj JS, Prause N, Hannum R, Noll A, Cheung R, Giustini AB, Jakab SS, Nobbe A, Patton H, Perumalswami P, Spoutz[...]

Mechanisms and therapeutic insights into MASH-associated fibrosis

Zhu Y, Cai B. Mechanisms and therapeutic insights into MASH-associated fibrosis. Trends Endocrinol Metab. 2025 Sep 26:S1043-2760(25)00196-1. doi: 10.1016/j.tem.2025.09.004. Epub ahead of print. PMID: 41015698.

Functional alterations across motor, visual, and attention cerebellar and cortical networks in patients with asymptomatic spinal cord compression

Kostiuk A, Jafari M, Wang C, Mayer E, Salamon N, Holly LT, Ellingson BM. Functional alterations across motor, visual, and attention cerebellar and cortical networks[...]